TANG CAPITAL MANAGEMENT LLC - 31 Mar 2025 SCHEDULE 13G/A Report for KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
KALV
Shares outstanding
49,917,152 shares
Disclosed Ownership
4,941,798 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:15:24 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 9.9% ownership in KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV) on 31 Mar 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 9.9% 4,941,798 0 4,941,798 /s/ Kevin Tang Manager
KEVIN TANG 9.9% 4,941,798 0 4,941,798 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 6.6% 3,279,836 0 3,279,836 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 1.4% 706,962 0 706,962 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 1.7% 855,000 0 855,000 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0.2% 100,000 0 100,000 /s/ Kevin Tang Chief Executive Officer

Sponsored